Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Lemaitre Vascular (LMAT) Interest Expenses (2020 - 2025)

Lemaitre Vascular (LMAT) has disclosed Interest Expenses for 7 consecutive years, with $1.3 million as the latest value for Q4 2025.

  • Quarterly Interest Expenses rose 533.17% to $1.3 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $5.2 million through Dec 2025, up 2428.78% year-over-year, with the annual reading at $5.2 million for FY2025, 2428.78% up from the prior year.
  • Interest Expenses for Q4 2025 was $1.3 million at Lemaitre Vascular, roughly flat from $1.3 million in the prior quarter.
  • The five-year high for Interest Expenses was $1.3 million in Q2 2025, with the low at $205000.0 in Q4 2024.
  • Average Interest Expenses over 3 years is $845333.3, with a median of $621000.0 recorded in 2021.
  • Peak annual rise in Interest Expenses hit 650.0% in 2021, while the deepest fall reached 9.0% in 2021.
  • Over 3 years, Interest Expenses stood at $526000.0 in 2021, then tumbled by 61.03% to $205000.0 in 2024, then skyrocketed by 533.17% to $1.3 million in 2025.
  • According to Business Quant data, Interest Expenses over the past three periods came in at $1.3 million, $1.3 million, and $1.3 million for Q4 2025, Q3 2025, and Q2 2025 respectively.